Semaglutide’s Impact on Appetite and Satiety in American Males: An fMRI Study
Reading Time: 2 minutes Introduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a promising therapeutic option for managing type 2 diabetes and obesity. Its role in modulating appetite and enhancing satiety has been of particular interest in recent research. This article delves into a detailed study that utilized functional magnetic resonance imaging (fMRI) to understand how semaglutide affects appetite and satiety specifically in American males, a demographic with a high prevalence of obesity. Study Design and Methodology The study involved a cohort of American males aged between 30 and 60, all diagnosed with obesity but otherwise healthy. Participants were randomly assigned...


